• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素和雌激素在化脓性汗腺炎中的作用——一项系统评价

The Role of Androgens and Estrogens in Hidradenitis Suppurativa - A Systematic Review.

作者信息

Riis Peter Theut, Ring Hans Christian, Themstrup Lotte, Jemec Gregor Borut

机构信息

Peter Theut Riis, MD, Department of Dermatology University Hospital Zealand, Køgevej 7-13, 4000 Roskilde, Denmark;

出版信息

Acta Dermatovenerol Croat. 2016 Dec;24(4):239-249.

PMID:28128074
Abstract

Hidradenitis suppurativa (HS) is an inflammatory skin disease. Several observations imply that sex hormones may play a role in its pathogenesis. HS is more common in women, and the disease severity appears to vary in intensity according to the menstrual cycle. In addition, parallels have been drawn between HS and acne vulgaris, suggesting that sex hormones may play a role in the condition. The role of androgens and estrogens in HS has therefore been explored in numerous observational and some interventional studies; however, the studies have often reported conflicting results. This systematic review includes 59 unique articles and aims to give an overview of the available research. Articles containing information on natural variation, severity changes during menstruation and pregnancy, as well as articles on serum levels of hormones in patients with HS and the therapeutic options of hormonal manipulation therapy have all been included and are presented in this systematic review. Our results show that patients with HS do not seem to have increased levels of sex hormones and that their hormone levels lie within the normal range. While decreasing levels of progesterone and estrogen seem to coincide with disease flares in premenopausal women, the association is speculative and requires experimental confirmation. Antiandrogen treatment could be a valuable approach in treating HS, however randomized control trials are lacking.

摘要

化脓性汗腺炎(HS)是一种炎症性皮肤病。多项观察结果表明,性激素可能在其发病机制中起作用。HS在女性中更为常见,并且疾病严重程度似乎会根据月经周期而有所不同。此外,HS与寻常痤疮之间存在相似之处,这表明性激素可能在该病中起作用。因此,在众多观察性研究和一些干预性研究中探讨了雄激素和雌激素在HS中的作用;然而,这些研究往往报告了相互矛盾的结果。本系统评价纳入了59篇独特的文章,旨在对现有研究进行概述。包含自然变异、月经和孕期严重程度变化信息的文章,以及关于HS患者血清激素水平和激素操纵疗法治疗选择的文章均已纳入本系统评价并呈现。我们的结果表明,HS患者的性激素水平似乎并未升高,且其激素水平处于正常范围内。虽然绝经前女性孕酮和雌激素水平的下降似乎与疾病发作同时出现,但这种关联只是推测性的,需要实验证实。抗雄激素治疗可能是治疗HS的一种有价值的方法,然而缺乏随机对照试验。

相似文献

1
The Role of Androgens and Estrogens in Hidradenitis Suppurativa - A Systematic Review.雄激素和雌激素在化脓性汗腺炎中的作用——一项系统评价
Acta Dermatovenerol Croat. 2016 Dec;24(4):239-249.
2
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.使用比美吉珠单抗治疗化脓性汗腺炎的III期BE HEARD I和II试验的汇总数据,对化脓性汗腺炎生活质量(HiSQOL©)问卷进行心理测量学验证和解释阈值分析。
Br J Dermatol. 2025 Jun 20;193(1):93-104. doi: 10.1093/bjd/ljaf067.
3
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.化脓性汗腺炎生活质量(HiSQOL)评分在成年化脓性汗腺炎患者真实世界应用中的验证。
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.
4
A qualitative interview study exploring patients' views and experiences of treatment for hidradenitis suppurativa in the UK.一项定性访谈研究,探讨英国化脓性汗腺炎患者对治疗的看法和经历。
Br J Dermatol. 2025 Jun 20;193(1):85-92. doi: 10.1093/bjd/ljaf046.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Treatments for seizures in catamenial (menstrual-related) epilepsy.月经性(与月经相关)癫痫发作的治疗。
Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225. doi: 10.1002/14651858.CD013225.pub3.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

引用本文的文献

1
The Role of Sex in Body Composition Differences in Hidradenitis Suppurativa: Insights from Bioelectrical Impedance Analysis.性别在化脓性汗腺炎身体成分差异中的作用:生物电阻抗分析的见解
J Clin Med. 2025 Apr 17;14(8):2760. doi: 10.3390/jcm14082760.
2
Beyond the skin: endocrine, psychological and nutritional aspects in women with hidradenitis suppurativa.超越皮肤层面:化脓性汗腺炎女性患者的内分泌、心理及营养方面
J Transl Med. 2025 Feb 10;23(1):167. doi: 10.1186/s12967-025-06175-1.
3
A diverse hidradenitis suppurativa cohort: A retrospective cross-sectional study of 13,130 patients from a large US health care system database from 1995 to 2022.
一个多样化的化脓性汗腺炎队列:一项对1995年至2022年来自美国一个大型医疗保健系统数据库的13130名患者的回顾性横断面研究。
J Am Acad Dermatol. 2025 Mar;92(3):487-494. doi: 10.1016/j.jaad.2024.10.073. Epub 2024 Nov 10.
4
Demographic Data, Risk Factors, and Disease Burden of HS Patients in Lithuania at a Reference Center.立陶宛某参考中心HS患者的人口统计学数据、风险因素及疾病负担
Healthcare (Basel). 2024 Sep 14;12(18):1849. doi: 10.3390/healthcare12181849.
5
Tissue comparability and bias in hidradenitis suppurativa transcriptomic studies.化脓性汗腺炎转录组学研究中的组织可比性与偏差
Proc Natl Acad Sci U S A. 2024 Jun 4;121(23):e2404503121. doi: 10.1073/pnas.2404503121. Epub 2024 May 28.
6
Prevalence and Characteristics of Hidradenitis Suppurativa in the Northern Finland Birth Cohort 1986 Study: A Cross-sectional Study of 2,775 Subjects.芬兰北部出生队列 1986 年研究中的化脓性汗腺炎患病率和特征:一项 2775 名受试者的横断面研究。
Acta Derm Venereol. 2024 Jan 10;104:adv14732. doi: 10.2340/actadv.v104.14732.
7
Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa.表观遗传开关重塑了大汗腺炎中上皮祖细胞特征,并驱动其炎症发病机制。
Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2315096120. doi: 10.1073/pnas.2315096120. Epub 2023 Nov 27.
8
Pathogenesis of Hidradenitis Suppurativa: An Immunological Perspective.化脓性汗腺炎的发病机制:免疫学视角
Indian J Dermatol. 2023 May-Jun;68(3):296-300. doi: 10.4103/ijd.ijd_594_22.
9
Sex-biased immunological processes drive hidradenitis suppurativa.性别偏向的免疫过程导致化脓性汗腺炎。
Front Immunol. 2023 May 4;14:1167021. doi: 10.3389/fimmu.2023.1167021. eCollection 2023.
10
Successful treatment of Hidradenitis Suppurativa with tofacitinib: two cases and a review of the literature.托法替布成功治疗化脓性汗腺炎:两例病例及文献综述
Oxf Med Case Reports. 2023 Mar 25;2023(3):omad003. doi: 10.1093/omcr/omad003. eCollection 2023 Mar.